KPX Lifescience Co Ltd
KOSDAQ:114450
KPX Lifescience Co Ltd
Research & Development
KPX Lifescience Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KPX Lifescience Co Ltd
KOSDAQ:114450
|
Research & Development
-₩735m
|
CAGR 3-Years
-89%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Research & Development
-₩37.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Research & Development
-₩10.7B
|
CAGR 3-Years
-158%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Research & Development
-₩15.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Research & Development
-₩20.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Research & Development
-₩171.1B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
-36%
|
|
KPX Lifescience Co Ltd
Glance View
KPX LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 61 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.
See Also
What is KPX Lifescience Co Ltd's Research & Development?
Research & Development
-735m
KRW
Based on the financial report for Dec 31, 2024, KPX Lifescience Co Ltd's Research & Development amounts to -735m KRW.
What is KPX Lifescience Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-89%
Over the last year, the Research & Development growth was -556%. The average annual Research & Development growth rates for KPX Lifescience Co Ltd have been -89% over the past three years .
